menu
    • menu

    Company profile for Immedica Pharma

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immedica is a rapidly expanding private European pharmaceutical group with its headquarters situated in Stockholm, Sweden, and boasting commercial coverage across Europe and the Middle East. Moreover, Immedica distributes some of its products to various regions worldwide through a network of regional distributors. Leveraging substantial expertise and experience in commercializing niche and specialty care products throughout Eu...
    Immedica is a rapidly expanding private European pharmaceutical group with its headquarters situated in Stockholm, Sweden, and boasting commercial coverage across Europe and the Middle East. Moreover, Immedica distributes some of its products to various regions worldwide through a network of regional distributors. Leveraging substantial expertise and experience in commercializing niche and specialty care products throughout Europe and the Middle East, Immedica's management team possesses a remarkable track record in the international niche pharmaceutical market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immedica PharmaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Solnavägen 3H 113 63 Stockholm
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immedica.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immedica-pharma-ab/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ovid Therapeutics Enters Agreement with Immedica Pharma
    Ovid Therapeutics Enters Agreement with Immedica Pharma

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105008/0/en/Ovid-Therapeutics-Enters-Agreement-with-Immedica-Pharma-AB-for-Sale-of-Future-Ganaxolone-Royalties.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Immedica to Acquire Biopharma Company Marinus Pharmaceuticals
    Immedica to Acquire Biopharma Company Marinus Pharmaceuticals

    30 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241230307666/en

    BUSINESSWIRE
    30 Dec 2024
    Share Share
    KKR, Impilo Partner In Immedica Rare Disease Platform
    KKR, Impilo Partner In Immedica Rare Disease Platform

    22 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240422283835/en

    BUSINESSWIRE
    22 Apr 2024
    Share Share
    PharmaMar signs an agreement with Immedica Pharma to market lurbinectedin
    PharmaMar signs an agreement with Immedica Pharma to market lurbinectedin

    29 Apr 2020

    // MARKETSCREENER

    https://www.marketscreener.com/PHARMA-MAR-S-A-24798227/news/Pharma-Mar-S-A-PharmaMar-signs-an-agreement-with-Immedica-Pharma-to-market-lurbinectedin-in-Easter-30492726/

    MARKETSCREENER
    29 Apr 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search